CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jul. 02, 2022	Jan. 01, 2022
Current assets:
Cash and cash equivalents	$ 17,463	$ 30,490
Patient accounts receivable	246,026	218,917
Receivables under insured programs	6,605	6,373
Prepaid expenses	19,634	14,233
Other current assets	3,389	9,202
Total current assets	293,117	279,215
Property and equipment, net	27,490	31,374
Operating lease right of use assets	49,899	51,992
Goodwill	1,367,143	1,835,580
Intangible assets, net	100,355	102,851
Receivables under insured programs	23,378	25,530
Other long-term assets	47,600	7,829
Total assets	1,908,982	2,334,371
Current liabilities:
Accounts payable and other accrued liabilities	53,370	52,624
Accrued payroll and employee benefits	45,224	54,565
Current portion of insurance reserves - insured programs	6,605	6,373
Current portion of insurance reserves	16,984	13,466
Securitization obligations	150,000	120,000
Current portion of long-term obligations	8,600	8,600
Current portion of operating lease liabilities	10,858	13,534
Current portion of deferred payroll taxes	25,523	25,523
Other current liabilities	44,001	50,146
Total current liabilities	361,165	344,831
Revolving credit facility	15,000
Long-term obligations, less current portion	1,224,383	1,226,517
Long-term insurance reserves - insured programs	23,378	25,530
Long-term insurance reserves	36,408	35,122
Operating lease liabilities, less current portion	42,393	44,682
Deferred income taxes	2,957	3,046
Other long-term liabilities	1,026	16,692
Total liabilities	1,706,710	1,696,420
Commitments and contingencies (Note 11)
Deferred restricted stock units	2,135	2,135
Stockholders’ equity:
Preferred stock, $0.01 par value as of July 2, 2022 and no par value as of January 2, 2021, 5,000,000 shares authorized; none issued or outstanding
Common stock, $0.01 par value, 1,000,000,000 shares authorized; 185,918,240 and 184,732,268 issued and outstanding, respectively	1,859	1,847
Additional paid-in capital	1,221,507	1,208,645
Accumulated deficit	(1,023,229)	(574,676)
Total stockholders’ equity	200,137	635,816
Total liabilities, deferred restricted stock units, and stockholders’ equity	$ 1,908,982	$ 2,334,371